Source:
https://t.me/TheLightPaperDistribution
PEER-REVIEWED CASE REPORTS SHOWING CAUSALITY OR STRONG ASSOCIATION BETWEEN COVID-19 VACCINES AND INJURY OR DEATH
React19.org contains a list of 1250 peer-reviewed case reports studying the relationship between Covid-19 vaccines and adverse side effects or death. This document contains only those case studies (240) that show causality or strong association between Covid-19 vaccines and injury or death. Causative or associative language can be found in either the extract, body, discussion or conclusion of the following reports. (Source: https://react19.org/1250-covid-vaccine-reports/)
________________________________________________________________________________________________________
Innate Immune Suppression by SARS-CO-V2 mRNA Vaccines
https://www.sciencedirect.com/science/article/pii/S027869152200206X
The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide the mRNA from cellular defenses and promote a longer biological half-life and high production of spike protein. However, the immune response to the vaccine is very different from that to a SARS-CoV-2 infection. In this paper, we present evidence that vaccination induces a profound impairment in type I interferon signaling, which has diverse adverse consequences to human health. Immune cells that have taken up the vaccine nanoparticles release into circulation large numbers of exosomes containing spike protein along with critical microRNAs that induce a signaling response in recipient cells at distant sites. We also identify potential profound disturbances in regulatory control of protein synthesis and cancer surveillance. These disturbances potentially have a causal link to neurodegenerative disease, myocarditis, immune thrombocytopenia, Bell's palsy, liver disease, impaired adaptive immunity, impaired DNA damage response and tumorigenesis. We show evidence from the VAERS database supporting our hypothesis. We believe a comprehensive risk/benefit assessment of the mRNA vaccines questions them as positive contributors to public health.
+ + +
Autoimmune Disease
A Case Series and Literature Review of the Association of COVID-19 Vaccination with Autoimmune Diseases: Causality or Chance?
Immune mediated events timely associated with COVID-19 vaccine
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560855/
Bell’s Palsy/Nerve Palsy
Acute Abducens Nerve Palsy following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34044114/
34yoF with Bell’s Palsy 2 Days after Moderna
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143982/
37yoM with Bell’s Palsy after Pfizer
https://pubmed.ncbi.nlm.nih.gov/33611630/
61yoM with Bell’s Palsy after Each Dose of Pfizer
https://pubmed.ncbi.nlm.nih.gov/34281950/
Rate of Bell’s Palsy following mRNA Vaccination is 2-3x Higher than Expected
https://pubmed.ncbi.nlm.nih.gov/34111409/
Cancer
Rapid Progression of T-Cell Lymphoma following Pfizer Booster
https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full
13 Cases of Cervical Lymphadenopathy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241354/
Review of 24 Cases of Lymphadenopathy and their Ultrasound Findings in the US
https://pubmed.ncbi.nlm.nih.gov/34356507/
Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Management
https://pubmed.ncbi.nlm.nih.gov/34503150/
163 Cases of Axillary Adenopathy Following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34257025/
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full
Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy
https://pubmed.ncbi.nlm.nih.gov/34432391/
Axillary lymphadenopathy after vaccination in a woman with breast cancer
https://pubmed.ncbi.nlm.nih.gov/34940788/
Fine needle aspiration in a vaccine associated lymphadenopathy
https://pubmed.ncbi.nlm.nih.gov/34286849/
Hypermetabolic lymphadenopathy following Pfizer, incidence assessed by FDG PET-CT and revelance to study interpretation, a review of 728 vaccinated patients
https://pubmed.ncbi.nlm.nih.go
Cardiac/Pulmonary
An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination
https://www.sciencedirect.com/science/article/pii/S1878540922001128
A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Mechanical Thrombectomy
https://pubmed.ncbi.nlm.nih.gov/35181646/
Acute Myocardial Infarction, Coronal Arteritis and Myocarditis after BNT162b2 mRNA Vaccination against Covid-19
https://www.preprints.org/manuscript/202209.0051/v1
Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524235/
Myocarditis after Covid-19 mRNA Vaccination
https://www.nejm.org/doi/10.1056/NEJMc2109975
Unprovoked Submassive Saddle Pulmonary Embolism in an Adult Male After Pfizer COVID-19 Vaccination
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
https://jamanetwork.com/journals/jama/fullarticle/2788346
Autopsy-based Histopathological Characterization of Myocarditis after anti-SARS-CoV-2-Vaccination
https://pubmed.ncbi.nlm.nih.gov/36436002/
COVID-19 mRNA Vaccine-induced Pneumonitis
https://pubmed.ncbi.nlm.nih.gov/34707048/
Eosinophilic Pneumonia Associated to SARS-CoV-2 Vaccine
https://pubmed.ncbi.nlm.nih.gov/34803208/
Perimyocarditis in Adolescents after Pfizer Vaccine
https://academic.oup.com/jpids/article/10/10/962/6329543
COVID-19 Vaccine-induced Myocarditis: Case Report with Literature Review
https://www.sciencedirect.com/science/article/pii/S1871402121002253
Fulminant Myocarditis Requiring ECMO in a 60yoF following 2nd dose Pfizer
https://pubmed.ncbi.nlm.nih.gov/35650138/
Pericarditis following mRNA Vaccination
https://pubmed.ncbi.nlm.nih.gov/34364831/
Myocarditis in a 16yo, Late Gadolinium Enhancement
https://pubmed.ncbi.nlm.nih.gov/34778788/
3 Cases of Cardiac Manifestation following Pfizer
https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcab177/6311674
Myocarditis with BNT162b2 Messenger RNA COVID-19 Vaccine in a Series of Children
https://pubmed.ncbi.nlm.nih.gov/34374740/
Cardiac Arrhythmia after COVID-19 Vaccination versus Non–COVID-19 Vaccination: A Systematic Review and Meta-Analysis
https://www.medrxiv.org/content/10.1101/2022.11.21.22282554v1.full#ref-1
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547775/
Ad26.COV2.S Vaccine-Induced Thrombocytopenia Leading to Dural Sinus Thrombosis and Intracranial Hemorrhage Requiring Hemicraniectomy: A Case Report and Systematic Review
PE, TIA, and thrombocytopenia after J&J
https://pubmed.ncbi.nlm.nih.gov/34261635/
Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265377/
DVT and PE and positive HIT panel following mRNA Vaccine
https://pubmed.ncbi.nlm.nih.gov/34117206/
3 patients with venous thromboembolism following mRNA vaccination
https://pubmed.ncbi.nlm.nih.gov/34352418/
Thrombosis with Thrombocytopenia following Moderna
https://www.acpjournals.org/doi/full/10.7326/L21-0244
34yoF with vaccine induced thrombotic thrombocytopenia following Moderna
https://pubmed.ncbi.nlm.nih.gov/34804389/
Case report: vaccine-induced immune thrombotic thrombocytopenia in a pancreatic cancer patient after mRNA vaccination
https://pubmed.ncbi.nlm.nih.gov/34790684/
Case study of Thrombosis and Thrombocytopenia following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34781321/
Eltromopag for refractory vaccine-induced immune thrombotic thrombocytopenia in a 64yoF following AstraZeneca vaccination
https://pubmed.ncbi.nlm.nih.gov/34797474/
Acquired TTP following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34309715/
Denovo iTTP episode in a 38yoF following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34105244/
5 cases of prothrombotic immune thrombocytopenia after AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34323939/
Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna
https://pubmed.ncbi.nlm.nih.gov/34332437/
Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings
https://pubmed.ncbi.nlm.nih.gov/34355379/
3 cases of adolescents with Pfizer induced TTP
https://pubmed.ncbi.nlm.nih.gov/35373880/
Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34402235/
Possible risk of thrombotic events following AstraZeneca in women receiving estrogen
https://pubmed.ncbi.nlm.nih.gov/34734086/
Blood clots and bleeding events following Pfizer and AstraZeneca: an analysis of European data
https://pubmed.ncbi.nlm.nih.gov/34174723/
Venous thromboembolism, thrombocytopenia, and bleeding after vaccination with AstraZeneca in Denmark and Norway: a population based cohort study
https://pubmed.ncbi.nlm.nih.gov/33952445/
Association of AstraZeneca and Pfizer with major venous, arterial, or thrombocytopenic events: a population based cohort study of 46 million adults in England
https://pubmed.ncbi.nlm.nih.gov/35192597/
Arterial thrombosis following 1st dose AstraZeneca: a case series
https://pubmed.ncbi.nlm.nih.gov/35571586/
Late Onset VITT with cerebral venous sinus thrombosis
https://pubmed.ncbi.nlm.nih.gov/35093626/
Confusion and abdominal pain due to VITT following vaccination
https://pubmed.ncbi.nlm.nih.gov/34346657/
Avoidance of vaccine for thrombocytopenic patients and/or myelodysplastic patients or vaccinate and keep them under strict controls - Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34344867/
Malignant CVA due to VITT following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34341358/
Anti-platelet factor 4 IgG levels in VITT: persistent positivity through 7 months
https://pubmed.ncbi.nlm.nih.gov/35515079/
Thrombosis patterns and clinical outcome of VITT: a systematic review and meta-analysis
https://pubmed.ncbi.nlm.nih.gov/35339716/
Second dose VITT: rare but real
https://pubmed.ncbi.nlm.nih.gov/35482343/
Mechanisms of immunothrombosis in VITT compared to natural COVID infection
https://pubmed.ncbi.nlm.nih.gov/34051613/
3 cases of immune thrombocytopenia following AstraZeneca in Thailand
https://pubmed.ncbi.nlm.nih.gov/34483267/
Ear/Nose/Throat
Persisting, unilateral tinnitus after mRNA vaccine https://journals.lww.com/jfmpc/Fulltext/2022/06000/Persisting,_unilateral_tinnitus_22_days_after.175.aspx
3 cases of Tinnitus following mRNA vaccination
https://pubmed.ncbi.nlm.nih.gov/34120553/
COVID-vaccine associated tinnitus: a review of VAERS
https://pubmed.ncbi.nlm.nih.gov/35096388/
Vestibular neuritis in a 54yoM following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34898387
Bilateral Vocal Fold Paralysis after 3rd dose Pfizer requiring intubation and tracheostomy
https://pubmed.ncbi.nlm.nih.gov/35762144/
Ulcers of bilateral palate mucosa following Moderna in a 58yoF
https://pubmed.ncbi.nlm.nih.gov/35114426/
Endocrine
5 Cases of Adrenal Crisis following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34358373/
Fertility
Covid-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors
https://onlinelibrary.wiley.com/doi/10.1111/andr.13209
Guillane-Barre Syndrome
Sensory Ataxic GBS with Immunoglobulin G Anti-GM1 Antibodies following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34871447/
Hematology
Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma
https://pubmed.ncbi.nlm.nih.gov/34459725/
Rituximab-induced Acute Lympholysis and Pancytopenia after Moderna in a 71yoM with b-cell Lymphoplasmacytic Lymphoma
https://pubmed.ncbi.nlm.nih.gov/34429981/
Successful Venous Thromboprophylaxis in a Patient with AstraZeneca-induced VITT
https://pubmed.ncbi.nlm.nih.gov/34496889/
Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways
Arterial Thrombosis in an Unusual Site (ulnar artery) in a 68yoM following 3rd dose of Moderna
https://pubmed.ncbi.nlm.nih.gov/35645305/
Changes in Blood Viscosity after COVID-19 vaccination
https://pubmed.ncbi.nlm.nih.gov/34868465/
Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways
Vaccine induced thrombocytopenia and thrombosis: venous endotheliopathy leading to venous combined micro-macrothrombosis
https://pubmed.ncbi.nlm.nih.gov/34833382/
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
https://pubmed.ncbi.nlm.nih.gov/34455073/
Safety warning for AstraZeneca in patients with sickle cell disease
Acquired Hemophilia A following COVID-19 Vaccination—The Importance of Prompt
Diagnosis: A Case Report
https://www.trasci.com/article/S1473-0502(22)00269-5/fulltext
Inflammation/Arthritis
2 Cases of Löfgren’s Syndrome following AstraZeneca and Moderna Vaccination
https://pubmed.ncbi.nlm.nih.gov/34835244/
Cubital Tunnel Syndrome Temporally following Moderna in a 28yoF
https://pubmed.ncbi.nlm.nih.gov/35448837/
New-onset Polymyalgia Rheumatica in a 80yoF following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34897152/
50yoM with HSP including IgA Leukocytoclastic Vasculitis on Skin Biopsy following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34984055/
Rash, Arthritis, Swelling, Muscle weakness following AstraZeneca
https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27175
Polyarthralgia and Myalgia Syndrome after AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34463066/
Remitting seronegative symmetrical synovitis with pitting edema following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34348912/
Pheochromocytoma Crisis following J&J vaccination
https://pubmed.ncbi.nlm.nih.gov/34707965/
Chronic Inflammatory Demyelinating Polyneuropathy after AstraZeneca vaccination:
https://pubmed.ncbi.nlm.nih.gov/34960248/
Miscellaneous
New onset Evans Syndrome associated with systemic lupus erythematosus after Pfizer vaccination
https://pubmed.ncbi.nlm.nih.gov/34687421/
Hemophagocytic lymphohistiocytosis (HLH) in a 14yoF requiring VA ECMO
https://pubmed.ncbi.nlm.nih.gov/35455321/
3 cases of HLH following AstraZeneca
https://jcp.bmj.com/content/early/2021/07/22/jclinpath-2021-207760
Multiple Sclerosis
New onset MS in a 32yoF patient following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34804388/
Multisystem Inflammation
Multisystem Inflammatory Syndrome after Covid 19 Vaccination
https://www.mdpi.com/2076-393X/9/11/1353/pd
Beware of the ambiguous enemy of multisystem inflammatory syndrome in adult (MIS‐A) following Covid‐19 infection or vaccination
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626603/
Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618727
Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781649/
Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection
https://pubmed.ncbi.nlm.nih.gov/34852213/
Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843319/
Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V)
https://pubmed.ncbi.nlm.nih.gov/34326117/
MIS in 2 adults with short interval between COVID-19 infection and subsequent vaccination
https://pubmed.ncbi.nlm.nih.gov/35320702/
Two cases of MIS-V: 15yoF and 17yoF
https://pubmed.ncbi.nlm.nih.gov/35275051/
MIS resulting in reversible autoimmune cardiomyopathy in a 25yoM following 3rd dose of COVID vaccination
https://pubmed.ncbi.nlm.nih.gov/35747051/
MIS-V with erythema multiforme-like rash in a 62yoM following Pfizer
https://pubmed.ncbi.nlm.nih.gov/35248401/
Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V)
https://pubmed.ncbi.nlm.nih.gov/34326117/
MIS-V in a 22yoF following Pfizer
https://pubmed.ncbi.nlm.nih.gov/35719439/
Multisystem inflammatory syndrome in a 12yo male following Pfizerhttps://pubmed.ncbi.nlm.nih.gov/34978781/
Multisystem inflammatory Syndrome in a 12 year old boy after Pfizer
https://pubmed.ncbi.nlm.nih.gov/34955518/
MIS in a 12yoM following Pfizer
https://pubmed.ncbi.nlm.nih.gov/35062704/
Myasthenia Gravis
Fatal Myasthenic Crisis in a 55yoM following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/35449619/
New onset Myasthenia Gravis in 82yoM following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34709075/
Nervous System
1 case HSV Meningitis following Pfizer
https://pubmed.ncbi.nlm.nih.gov/35097240/
Neuromyelitis Optic in a Healthy Female following Moderna
https://pubmed.ncbi.nlm.nih.gov/34660149/
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Optic Neuropathy after Pfizer and Astrazeneca: a report of 2 cases
https://pubmed.ncbi.nlm.nih.gov/34906029/
Bilateral Optic Neuritis after AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/35098359/
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547775/
Neuromuscular
Rhabdomyolysis after Moderna
https://pubmed.ncbi.nlm.nih.gov/34150372/
New Onset Mainly Guttate Psoriasis after Pfizer
https://pubmed.ncbi.nlm.nih.gov/34309932/
Pustuluar Psoriasis following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34398977/
Parkinson’s Disease
COVID-19 Vaccine Associated Parkinson's Disease, A Prion Disease Signal in the UK Yellow Card Adverse Event Database
Psychosis
First Episode Psychosis Following COVID-19 Vaccination: a Case Report
https://pubmed.ncbi.nlm.nih.gov/36170703/
Retinal/Ocular Events
Retinal Vascular Events after mRNA Vaccination
https://pubmed.ncbi.nlm.nih.gov/34835280/
Central Retinal Vein Occlusion
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597478/
Combined Retinal Artery and Vein Occlusion after mRNA Vaccination
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689963/
Acute Retinal Necrosis after mRNA Vaccination
https://www.tandfonline.com/doi/abs/10.1080/09273948.2021.2001541
Branch Retinal Vein Occlusion after mRNA Vaccination
https://pubmed.ncbi.nlm.nih.gov/34918688/
Corneal graft rejection after Vaccination
https://pubmed.ncbi.nlm.nih.gov/34426655/
7 Cases of Corneal Graft Rejection after Vaccination
https://pubmed.ncbi.nlm.nih.gov/34835205/
Corneal Graft Rejection Associated with mRNA Vaccines
https://pubmed.ncbi.nlm.nih.gov/34281760/
Corneal Graft Rejection after mRNA Vaccination
https://pubmed.ncbi.nlm.nih.gov/34690266/
Corneal Transplant and DMEK Rejection after mRNA Vaccination
https://pubmed.ncbi.nlm.nih.gov/33910885/
Corneal Rejection may Occur Soon after either Dose of mRNA Vaccine
https://pubmed.ncbi.nlm.nih.gov/34620770/
Patient Diagnosed with Acute Corneal Rejection Due to mRNA Vaccination
https://pubmed.ncbi.nlm.nih.gov/34827040/
Large Series of Patients with Retinal Vein Occlusion following COVID-a9 Vaccination
https://pubmed.ncbi.nlm.nih.gov/35113504/
Possible Sight-threatening Ocular Thrombotic Conditions after COVID-19 Vaccination
https://pubmed.ncbi.nlm.nih.gov/35079224/
Retinal Veinous Occlusion Increase Post mRNA Vaccination in the Past Year
https://pubmed.ncbi.nlm.nih.gov/35648014/
Retinal Detachment in a Healthy Young Woman after COVID-19 Vaccination
https://www.jem-journal.com/article/S0736-4679(21)00611-9/fulltext
Acute Macular Neuroretinopathy following COVID-19 Vaccination
Central Serous Chorioretinopathy following Pfizer (38yoM military physician)
https://pubmed.ncbi.nlm.nih.gov/34949501/
Serous Chorioretinopathy
https://pubmed.ncbi.nlm.nih.gov/35577701/
Acute Central Serous Retinopathy
https://pubmed.ncbi.nlm.nih.gov/34151047/
Bilateral Panuveitis Mimicking Vogt-Koyanagi-Harada Disease
https://pubmed.ncbi.nlm.nih.gov/35113750/
Panuveitis
https://pubmed.ncbi.nlm.nih.gov/34213988/
42 Cases of Uveitis and Other Ocular Complications
https://pubmed.ncbi.nlm.nih.gov/34945256/
Reduction of Visual Acuity
https://link.springer.com/article/10.1007/s00011-021-01476-9
Shingles
Booster Shots Adversely Affect Immune Response
https://virologyj.biomedcentral.com/articles/10.1186/s12985-022-01831-0
2 Cases Herpes Zoster Ophthalmic following Pfizer
https://pubmed.ncbi.nlm.nih.gov/35097240/
Persistent Varicella Zoster Virus Infection following mRNA COVID-19 Vaccination was Associated with the Presence of Encoded Spike Protein in the Lesion
https://onlinelibrary.wiley.com/doi/10.1002/cia2.12278
Herpes Zoster Ophthalmicus in 2 Women after Pfizer–BioNTech (BNT162b2) Vaccine
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661555/
2 cases (80yoF, 69yoF) of Herpes Ophthalmicus following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34585774/
10 Cases of Herpes Zoster following Covid Vaccination
https://pubmed.ncbi.nlm.nih.gov/35746994/
2 cases of herpes zoster in healthy young adults following vaccination
https://pubmed.ncbi.nlm.nih.gov/34363257/
52 Cases Varicella Zoster Reactivation and mRNA Vaccines as a Trigger
https://pubmed.ncbi.nlm.nih.gov/34316507/
A Case of varicella-zoster Virus after Pfizer with No Pre-existing Conditions
https://pubmed.ncbi.nlm.nih.gov/34390376/.
Skin Infections
CMV and Pericarditis in Temporal Association with mRNA Vaccines
https://pubmed.ncbi.nlm.nih.gov/35116025/
1 case HSV Meningitis following Pfizer
https://pubmed.ncbi.nlm.nih.gov/35097240/
Erythema Nodosum
https://pubmed.ncbi.nlm.nih.gov/35308066/
Alopecia Areata
https://pubmed.ncbi.nlm.nih.gov/35571458/
Cutaneous and allergic reactions
https://pubmed.ncbi.nlm.nih.gov/34791757/
Sweet Syndrome with Vasculitis
https://pubmed.ncbi.nlm.nih.gov/34835143/
Sweet Syndrome following SARS CO-V2 Vaccination
https://www.mdpi.com/2076-393X/9/11/1212/
Pemphigus vulgaris after COVID-19 vaccination: one new onset and two cases with severe
Aggravation
https://pubmed.ncbi.nlm.nih.gov/35187768/
Spontaneous urticaria after Pfizer vaccine
https://pubmed.ncbi.nlm.nih.gov/34692313/
Pityriasis-rosea like eruption post-vaccination in a young male
https://pubmed.ncbi.nlm.nih.gov/34165237
35yoM with Pityriasis rosea-like eruption after Pfizer
https://pubmed.ncbi.nlm.nih.gov/33904157/
66yoM with Pityriasis rosea after Pfizer
https://pubmed.ncbi.nlm.nih.gov/34435935
Pityriasis rubra pilaris following Astra Zeneca
https://pubmed.ncbi.nlm.nih.gov/34310778/
Lichenoid drug eruption following Pfizer
https://pubmed.ncbi.nlm.nih.gov/35097176/
3 cases of new onset acral hand lesions following mRNA vaccine
https://pubmed.ncbi.nlm.nih.gov/34310777/
Patients with eczematous cutaneous reactions following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34236729/
Exacerbation of Hailey-Hailey Disease following mRNA Vaccination
https://pubmed.ncbi.nlm.nih.gov/34436620/
Onset lichen planus following Pfizer
https://onlinelibrary.wiley.com/doi/10.1111/jdv.17504
46yoM with lichen planus eruption following AstraZeneca: a case report and review of
literature:
https://pubmed.ncbi.nlm.nih.gov/35386174/
Purpura annularis telangiectodes following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34236717/
Flagellate Purpura following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34416052/
Symmetrical drug related intertriginous and flexural exanthema like eruption following
AztraZeneca
https://pubmed.ncbi.nlm.nih.gov/34399001/
Palms and Soles Itchiness following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34391695/
Morphea (70yoF) after AstraZeneca and a second patient after COVID-19Infection
https://pubmed.ncbi.nlm.nih.gov/35449768/
Acral hemorrhage after second dose of vaccination
https://pubmed.ncbi.nlm.nih.gov/34697597/
Facial Pustular Neutrophilic Eruption following mRNA Vaccine
https://pubmed.ncbi.nlm.nih.gov/34319363/
Acute generalized exanthematous pustulosis induced by Moderna
https://pubmed.ncbi.nlm.nih.gov/34466640/
A flare up of pre-existing erythema multiforme following Pfizer:
https://pubmed.ncbi.nlm.nih.gov/33914926/
Atypical erythema multiforme related to Pfizer vaccine
https://pubmed.ncbi.nlm.nih.gov/34473839/
Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination
https://pubmed.ncbi.nlm.nih.gov/34292611/
Bullous pemphigoid triggered by covid-19 vaccine (Pfizer): rapid resolution with corticosteroid therapy
https://pubmed.ncbi.nlm.nih.gov/34786801/
Bullous Fixed Drug Eruption following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34482558/
Bullous eruption following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34416058/
Bullous Drug Eruption Rash following Moderna
https://pubmed.ncbi.nlm.nih.gov/34294590/
Bullous pemphigoid associated with covid-19 vaccines: an Italian multicentre study
https://pubmed.ncbi.nlm.nih.gov/35295599/
Bullous Drug Eruption Rash following Moderna
https://pubmed.ncbi.nlm.nih.gov/34294590/
Bullous eruption following Pfizer
https://pubmed.ncbi.nlm.nih.gov/34416058/
Bullous Fixed Drug Eruption following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34482558/
Bullous pemphigoid triggered by covid-19 vaccine (Pfizer): rapid resolution with corticosteroid therapy
https://pubmed.ncbi.nlm.nih.gov/34786801/
Atypical erythema multiforme related to Pfizer vaccine
https://pubmed.ncbi.nlm.nih.gov/34473839/
A flare up of pre-existing erythema multiforme following Pfizer
https://pubmed.ncbi.nlm.nih.gov/33914926/
Soft Tissue Filler Inflammatory Reaction after vaccination
https://pubmed.ncbi.nlm.nih.gov/34174156/
Clinical and pathologic correlation of cutaneous covid-19 vaccine reactions including V-REPP: a registry-based study
https://pubmed.ncbi.nlm.nih.gov/34517079/
New onset leukocytoclastic vasculitis following COVID-19 vaccination
https://pubmed.ncbi.nlm.nih.gov/33928638/
Cutaneous adverse events related to COVID-19 vaccines: a cross-sectional questionnaire-based study of 867 patients
https://pubmed.ncbi.nlm.nih.gov/34820975/
Soft Tissue Filler Inflammatory Reaction after vaccination
https://pubmed.ncbi.nlm.nih.gov/34174156/
Breast Implant seroma after mRNA vaccine
https://pubmed.ncbi.nlm.nih.gov/34405902/
Breast Implant Capsular Contracture following Moderna vaccination
https://pubmed.ncbi.nlm.nih.gov/34373851/
2 cases of Vitiligo triggered by COVID-19 vaccination
https://pubmed.ncbi.nlm.nih.gov/35145806/
Bacillus Calmette-Guerin scar erythema in a 14yoF post Pfizer vaccination
https://pubmed.ncbi.nlm.nih.gov/35175660/
Generalized papulovesicular eruption as a side effect of Pfizer vaccine
https://pubmed.ncbi.nlm.nih.gov/35371700/
Leukocytoclastic vasculitis after Pfizer
https://pubmed.ncbi.nlm.nih.gov/35099065/
Cutaneous vasculitis following AstraZeneca
https://pubmed.ncbi.nlm.nih.gov/34599716/
Leukocytoclastic vasculitis after exposure to AstraZeneca vaccine
https://pubmed.ncbi.nlm.nih.gov/34836739/
Sweet-like syndrome and multiple covid-arm syndrome following covid-19 vaccine: specific patterns in a series of 192 patients
https://pubmed.ncbi.nlm.nih.gov/35653233/
Possible case of mRNA vaccine induced small vessel vasculitis
https://pubmed.ncbi.nlm.nih.gov/34705320/
Cutaneous lymphocytic vasculitis following mRNA vaccine
https://pubmed.ncbi.nlm.nih.gov/34327795/
Relapse of microscopic polyangiitis after Pfizer vaccination: a case report
https://pubmed.ncbi.nlm.nih.gov/34251683/
2 cases of skin color discoloration following mRNA vaccination
https://pubmed.ncbi.nlm.nih.gov/34310755/
Moderna Vaccine Induced Skin Rash
https://pubmed.ncbi.nlm.nih.gov/34423142/
No comments:
Post a Comment
Note: only a member of this blog may post a comment.